2Yang W,Lu J, Weng J,et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China[J]. N Engl J Med,2010, 362(12): 1090-1101.
3Oh IS, Shimizu H, Satoh T,et al. Identification of nesfatin - 1 as a satiety molecule in the hypothalamus [ J ]. Nature, 2006, 443 (7112) : 709 -712.
4Yang X, Xiaoyan P, Mei D,et al. Nesfatin -1 inhibits ovarian epithe- lial carcinoma cell proliferation in vitro [ J ]. Biochemical and Biophysi- cal Research Communications, 2013, 440(4): 467-472.
5Sami G, Bilgin G, Suleyman A,et al. Ghrelins, obestatin, nesfatin- 1 and leptin levels in pregnant women with and without hyperemesis gravidarum [J]. Clinical Biochemistry,2013, 46 (9) : 828 -830.
6Hofmann T, Stengel A,Ahnis A,et al. NUCB2/nesfatin - 1 is associ- ated with elevated scores of anxiety in female obese patients [ J]. Psy- choneuroendocrinology ,2013, 38 ( 11 ) : 2502 - 2510.
7Emul M,Karamustafalioglu N,Kalelioglu T, et al. The nesfatinl level in male patients with manic episode and alterations of nesfatinl level after antipsychotic and electroconvulsive treatment[J]. Journal of Af- fective Disorders, 2013, 151 (3) : 849 - 853.
8Anwar GM,Yamamah G, Ibrahim A,et al. Nesfatin - 1 in childhood and adolescent obesity and its association with food intake, body com- position and insulin resistance [ J]. Regul Pept, 2014, 188:21 -24.
9Yang M,Zhang Z,Wang C,et al. Nesfatin - 1 action in the brain in- creases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet -induced Insulin Resistance [J]. Diabetes, 2012, 61 (18) : 1959 - 1968.
10Daia H,Lib X, Hea T,et al. Decreased plasma nesfatin - 1 levels in patients with acute myocardialinfarction [ J]. Peptides, 2013, 46: 167 - 171.
